Cdsco Guidelines
- All
- News
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
- Tuesday March 24, 2026
- Health | Reported by Tanushka Dutta
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
www.ndtv.com
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
- Wednesday March 11, 2026
- Health | Reported by Tanushka Dutta, Edited by Shreya Goswami
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
www.ndtv.com
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
www.ndtv.com
-
Drugs Control Organisation Issues COVID-19 Vaccines' Trial, Marketing Guidelines
- Friday September 18, 2020
- India News | ANI
The Central Drugs Standard Control Organisation (CDSCO) said the requirements and guidelines to conduct clinical trial or grant of permission for the marketing of new drugs including vaccines are prescribed under New Drugs and Clinical Trials Rules, 2019.
-
www.ndtv.com
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
- Tuesday March 24, 2026
- Health | Reported by Tanushka Dutta
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
www.ndtv.com
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
- Wednesday March 11, 2026
- Health | Reported by Tanushka Dutta, Edited by Shreya Goswami
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
www.ndtv.com
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
www.ndtv.com
-
Drugs Control Organisation Issues COVID-19 Vaccines' Trial, Marketing Guidelines
- Friday September 18, 2020
- India News | ANI
The Central Drugs Standard Control Organisation (CDSCO) said the requirements and guidelines to conduct clinical trial or grant of permission for the marketing of new drugs including vaccines are prescribed under New Drugs and Clinical Trials Rules, 2019.
-
www.ndtv.com